(Q37982803)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22320912%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

title

Bone marrow-derived proangiogenic cells in pancreatic cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22320912%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22320912%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

author name string

Yusuke Mizukami

series ordinal

1

1 reference

26 August 2017

publication date

1 March 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22320912%20AND%20SRC:MED&resulttype=core&format=json

Journal of Gastroenterology and Hepatology

22 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22320912%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

volume

27 Suppl 2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22320912%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

page(s)

23-26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22320912%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

cites work

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.07012.X

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.07012.X

Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.07012.X

Multicenter phase II study of the oral MEK inhibitor, CI-1040, in patients with advanced non-small-cell lung, breast, colon, and pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.07012.X

State-of-the-art imaging of pancreatic neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.07012.X

High expression of vascular endothelial growth factor predicts early recurrence and poor prognosis after curative resection for ductal adenocarcinoma of the pancreas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.07012.X

Gemcitabine plus bevacizumab compared with gemcitabine plus placebo in patients with advanced pancreatic cancer: phase III trial of the Cancer and Leukemia Group B (CALGB 80303).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.07012.X

Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.07012.X

Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.07012.X

Mechanisms of adverse effects of anti-VEGF therapy for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.07012.X

High interstitial fluid pressure - an obstacle in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.07012.X

Desmoplastic reaction in pancreatic cancer: role of pancreatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.07012.X

Microenvironmental regulation of metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.07012.X

Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.07012.X

Paradoxical roles of the immune system during cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.07012.X

Disruption of CCR5-dependent homing of regulatory T cells inhibits tumor growth in a murine model of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.07012.X

The pancreatic stellate cell: a star on the rise in pancreatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.07012.X

The bone marrow functionally contributes to liver fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.07012.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.07012.X

Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.07012.X

Bone marrow-derived myofibroblasts contribute to the mesenchymal stem cell niche and promote tumor growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.07012.X

PSF1, a DNA replication factor expressed widely in stem and progenitor cells, drives tumorigenic and metastatic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.07012.X

Instructive role of the vascular niche in promoting tumour growth and tissue repair by angiocrine factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.07012.X

Premetastatic lung "niche": is vascular endothelial growth factor receptor 1 activation required?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.07012.X

Inflammation and cancer: back to Virchow?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.07012.X

Bv8 regulates myeloid-cell-dependent tumour angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.07012.X

Systemic endocrine instigation of indolent tumor growth requires osteopontin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.07012.X

Human tumors instigate granulin-expressing hematopoietic cells that promote malignancy by activating stromal fibroblasts in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.07012.X

Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.07012.X

Sonic hedgehog is an early developmental marker of intraductal papillary mucinous neoplasms: clinical implications of mRNA levels in pancreatic juice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.07012.X

A paracrine requirement for hedgehog signalling in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.07012.X

GLI1 is regulated through Smoothened-independent mechanisms in neoplastic pancreatic ducts and mediates PDAC cell survival and transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.07012.X

Sonic hedgehog promotes desmoplasia in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.07012.X

Overexpression of smoothened activates the sonic hedgehog signaling pathway in pancreatic cancer-associated fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.07012.X

Hedgehog-mediated paracrine interaction between hepatic stellate cells and marrow-derived mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.07012.X

Hedgehog signaling alters adipocyte maturation of human mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.07012.X

Sonic hedgehog regulates branching morphogenesis in the mammalian lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.07012.X

Sonic hedgehog derived from human pancreatic cancer cells augments angiogenic function of endothelial progenitor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.07012.X

Hedgehog promotes neovascularization in pancreatic cancers by regulating Ang-1 and IGF-1 expression in bone-marrow derived pro-angiogenic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.07012.X

Magnetic resonance imaging monitors physiological changes with antihedgehog therapy in pancreatic adenocarcinoma xenograft model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.07012.X

Hedgehog inhibition prolongs survival in a genetically engineered mouse model of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.07012.X

10.1111/J.1440-1746.2011.07012.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22320912%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

1 reference